Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer.

Cancer genetics and cytogenetics - 1 Mar 2006

Erfani N, Razmkhah M, Talei A R, Pezeshki A M, Doroudchi M, Monabati A, Ghaderi A

Abstract excerpt

CTLA4 is a coinhibitory molecule expressed mainly on activated T lymphocytes. To test the putative involvement of CTLA-4 in inhibitory state of immunity to breast cancer, we genotyped 283 patients and 245 healthy control subjects for -1722 T/C, -1661 A/G, and -318 C/T single nucleotide polymorphisms in the promoter region of the CTLA4 gene. There were no significant differences in genotype, allele, or haplotype...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Antigens, CD
Share to Antigens, Differentiation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to CTLA-4 Antigen

Share to Gene Frequency

Share to Polymorphism, Restriction Fragment Length

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 16527605
DOI: 10.1016/j.cancergencyto.2005.07.020

Genes

CTLA4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer.PMID 16527605Read ↗

Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population.Semantic proximity Read ↗

Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis.Semantic proximity Read ↗

Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of northeast China.Semantic proximity Read ↗

ctla-4 gene variations may influence cervical cancer susceptibility.Semantic proximity Read ↗

Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.Semantic proximity Read ↗

Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk.Semantic proximity Read ↗

Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer.Semantic proximity Read ↗

CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers.Semantic proximity Read ↗

CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region.Semantic proximity Read ↗

CTLA4 gene variations and haplotypes in patients with lung cancer.Semantic proximity Read ↗

Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription.Semantic proximity Read ↗

[Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms with susceptibility to breast cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.